Figure 4. Levels of the sCD26, CEA, CA-19.9 and CA-72.4 in representative patients who developed hepatic (A; patient 34) and pulmonary (B; patient 39) metastases.

Black arrows indicate beginning and end of chemotherapy cycles and the upwards arrow indicates diagnosis of metastasis.